Adherence to secondary prevention recommendations after coronary artery bypass graft surgery

被引:2
|
作者
Keating, Taya [1 ]
AlAdalieh, Mohammad [1 ]
Chughtai, Zeb [1 ]
Javadpour, Seyed Hossein [1 ]
机构
[1] Mater Misericordiae Univ Hosp, Dept Cardiothorac Surg, Dublin 7, Ireland
关键词
Atherosclerosis; Coronary artery bypass grafting; Coronary artery disease; Cardiac surgery; Secondary prevention; SMOKING; DISEASE; MANAGEMENT;
D O I
10.1007/s11845-022-03129-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study was undertaken to assess and evaluate adherence to secondary prevention recommendations and risk factor modifications among a patient cohort at a single-tertiary centre in Ireland, following coronary artery bypass grafting (CABG). Methods This is a retrospective observational study analysing patients who had CABG from 2015 to 2020, identified via the Adult Cardiac Surgery Database. Patients were asked a number of questions either over the phone or via postal survey, regarding blood pressure, cholesterol control, adherence to medication, attendance at cardiac-rehab and lifestyle factors. Any repeat interventions following CABG were noted. Results A total of 540 patients were invited to take part in this study. One hundred seventy-three patients consented to participate, ranging from 47 to 86 years old. Postoperatively, 59% of participants attended cardiac rehab. 90.2% of patients report taking a statin, 91.3% report taking an antiplatelet, 77.4% report taking a beta-blocker and 75.7% take an antihypertensive. 93.1% of patients questioned in this study reported full compliance with their daily medications. Sixteen patients continue to have hypertension despite their current regimen. Thirteen patients continue to have hypercholesterolemia despite their current prescription. 62.4% of participants have quit smoking with only 4.6% remaining current smokers. No patients required re-operation, and eight patients required stenting. Compliance with diet and exercise modifications was suboptimal. Conclusion In this patient population, adherence to medication and control of risk factors is acceptable. However, there is room for improvement in terms of attendance at cardiac rehab (59%) and maintenance of a healthy lifestyle post-CABG.
引用
收藏
页码:1103 / 1108
页数:6
相关论文
共 50 条
  • [11] Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trial
    Heer, Tobias
    von Scheidt, Moritz
    Boening, Andreas
    Heyken, Clarissa
    Gusmini, Friederike
    de Waha, Antoinette
    Kuna, Constantin
    Fach, Andreas
    Grothusen, Christina
    Oberhoffer, Martin
    Knosalla, Christoph
    Walther, Thomas
    Danner, Bernhard C.
    Misfeld, Martin
    Wimmer-Greinecker, Gerhard
    Siepe, Matthias
    Grubitzsch, Herko
    Joost, Alexander
    Schaefer, Andreas
    Conradi, Lenard
    Cremer, Jochen
    Hamm, Christian
    Lange, Ruediger
    Radke, Peter W.
    Schulz, Rainer
    Laufer, Gunther
    Grieshaber, Philippe
    Attmann, Tim
    Schmoeckel, Michael
    Meyer, Alexander
    Ziegelhoeffer, Tibor
    Hambrecht, Rainer
    Sandner, Sigrid E.
    Kastrati, Adnan
    Schunkert, Heribert
    Zeymer, Uwe
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (03)
  • [12] Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery
    Schulman, S.
    Cybulsky, I.
    Delaney, J.
    THROMBOSIS RESEARCH, 2015, 135 (05) : 841 - 845
  • [13] Tension chylothorax after coronary artery bypass graft surgery
    Kara, Hakan
    Uzun, Kemal
    Bozok, Sahin
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 22 (02): : 419 - 422
  • [14] Quality of Life One Year after Coronary Artery Bypass Graft Surgery
    Taghipour, H. R.
    Naseri, M. H.
    Safiarian, R.
    Dadjoo, Y.
    Pishgoo, B.
    Mohebbi, H. A.
    Besheli, L. Daftari
    Malekzadeh, M.
    Kabir, A.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2011, 13 (03) : 171 - 177
  • [15] Evaluation of Preventive Cardiovascular Pharmacotherapy after Coronary Artery Bypass Graft Surgery
    Barry, Arden R.
    Koshman, Sheri L.
    Norris, Colleen M.
    Ross, David B.
    Pearson, Glen J.
    PHARMACOTHERAPY, 2014, 34 (05): : 464 - 472
  • [16] Postoperative Hyperglycemia and Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
    Tatsuishi, Wataru
    Adachi, Hitoshi
    Murata, Makoto
    Tomono, Junichi
    Okonogi, Shuichi
    Okada, Syuichi
    Hasegawa, Yutaka
    Ezure, Masahiko
    Kaneko, Tatsuo
    Ohshima, Shigeru
    CIRCULATION JOURNAL, 2015, 79 (01) : 112 - 118
  • [17] Medication adherence to secondary prevention for coronary artery disease
    Rossi, Emiliano
    Perman, Gaston
    Michelangelo, Hernan
    Alonzo, Claudia B.
    Brescacin, Laura
    Kopitowski, Karin S.
    Navarro Estrada, Jose L.
    MEDICINA-BUENOS AIRES, 2014, 74 (02) : 99 - 103
  • [18] Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
    Chang, Hyoung Woo
    Kim, Hee Jung
    Yoo, Jae Suk
    Kim, Dong Jin
    Cho, Kwang Ree
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
  • [19] Adherence to lifestyle changes after coronary artery bypass graft: Outcome of preoperative peer education
    Golaghaie, Farzaneh
    Esmaeili-Kalantari, Shahrzad
    Sarzaeem, Mahmoodreza
    Rafiei, Fatemeh
    PATIENT EDUCATION AND COUNSELING, 2019, 102 (12) : 2231 - 2237
  • [20] Outcome after coronary artery bypass graft surgery, coronary angioplasty and stenting
    Voelzke, Henry
    Henzler, Julia
    Menzel, Dirk
    Robinson, Daniel M.
    Hoffmann, Wolfgang
    Vogelgesang, Dirk
    John, Ulrich
    Motz, Wolfgang
    Rettig, Rainer
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 116 (01) : 46 - 52